Brief: Biofrontera Reaches Out-Of-Court Settlement With DUSA Pharmaceuticals
Nov 29 (Reuters) - BIOFRONTERA AG B8FGn.DE :
* REACHES OUT-OF-COURT SETTLEMENT WITH DUSA PHARMACEUTICALS,
INC.
* COMPANY AS WELL AS ITS DEFENDANT SUBSIDIARIES HAVE AGREED
TO PAY
DUSA USD 22.5 MILLION IN SETTLEMENT OF POTENTIAL CLAIMS
* FURTHER MUTUAL CLAIMS HAVE BEEN RELEASED
* HALF OF SETTLEMENT AMOUNT IS DUE UPON EXECUTION OF
AGREEMENT,
THEREAFTER ONE QUARTER ON EACH OF FIRST AND SECOND ANNIVERSARIES
AFTER EXECUTION OF AGREEMENT
* OF THIS AMOUNT, 50% WILL BE BORNE BY COMPANY AND 50% BY
BIOFRONTERA INC
Source text for Eikon: ID:nPexWVKw1a
Further company coverage: B8FGn.DE
(Gdansk Newsroom)
((Gdansk.Newsroom@thomsonreuters.com;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million